WCN26-3202 Plasma Exchange for Anti-glomerular Basement Membrane Antibody Disease with Dialysis Dependency: A Case Series on Clinical Outcomes and Safety

Read full text Summarise with VIRAT
Authors: Minoru Sakuragi, Miho Miyauchi, Misaki Kubo, Mea Aso, Sanae Ogura, Yuko Sokai, Yoshiki Tsuji, Keita P. Mori, Kazuo Torikoshi, Hiroyuki Suzuki, Toshiyuki Komiya, Eri Muso
+3 more Tomomi Endo, Takeshi Matsubara, Tatsuo Tsukamoto
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Anti-glomerular basement membrane (anti-GBM) antibody disease is a rare but highly aggressive autoimmune disorder targeting type IV collagen, leading to rapidly progressive glomerulonephritis and, occasionally, pulmonary hemorrhage. Despite advances in immunosuppressive therapy, renal outcomes remain poor, particularly in patients presenting with dialysis dependency. Plasma exchange (PEx) combined with immunosuppression is recommended as a key component of first-line therapy by major guidelines, including KDIGO 2021 and ASFA 2023.

Fields of Study & Subjects

Vasculitis and related conditions Renal Diseases and Glomerulopathies Systemic Lupus Erythematosus Research

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105208–105208
Publication date
25 March 2026
Language
EN